Table 1.
Characteristics of Study Participants by the Two Intervention Arms
| ATSM | NASM | |||||
|---|---|---|---|---|---|---|
| n | % | N | % | |||
| Gender | ||||||
| Male | 53 | 24.31 | 57 | 26.15 | ||
| Female | 165 | 75.69 | 161 | 73.85 | ||
| Site of Cancer | ||||||
| Lung | 33 | 15.14 | 37 | 16.97 | ||
| Breast | 87 | 39.91 | 89 | 40.83 | ||
| Colon | 32 | 14.68 | 30 | 13.76 | ||
| Other | 66 | 30.28 | 62 | 28.44 | ||
| Stage of Cancer | ||||||
| Early | 44 | 20.18 | 31 | 14.35 | ||
| Late | 174 | 79.82 | 185 | 85.65 | ||
| n | Mean | Std | N | Mean | Std | |
| Age | 217 | 57.07 | 12.01 | 218 | 57.28 | 11.84 |
| Comorbidity | 218 | 2.01 | 1.63 | 218 | 2.10 | 1.61 |
| Symptom severity at baseline |
212 | 35.63 | 22.50 | 215 | 32.65 | 21.01 |
| Symptom severity at 10 week |
175 | 20.73 | 18.05 | 180 | 20.80 | 19.16 |